Evidence map›Paper›PMID 41757198›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Outcome Risk Modeling for Disability-Free Longevity: Comparison of Random Forest and Random Survival Forest Methods.

Joseph C Vanghelof, Giorgos Tzimas, Lianlian Du, Roselyne Tchoua, Raj C Shah

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joseph C VanghelofRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Giorgos TzimasJarvis College of Computing and Digital Media, DePaul University, Chicago, IL.
Lianlian DuRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Roselyne TchouaJarvis College of Computing and Digital Media, DePaul University, Chicago, IL.
Raj C ShahRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: When creating risk prediction models for time-to-event data, methods that incorporate time are typically used. Random survival forests (RSF), an extension of random forests (RF), are one such class of models. We compared RSF to RF in the context of time-to-event outcomes in the ASPirin in Reducing Events in the Elderly (ASPREE) randomized controlled trial. We hypothesize that RSF will have superior discrimination and calibration versus RF. Methods: Participants from ASPREE residing outside the US or with missing data were excluded. A total of 2,291 participants were assigned 1:1 into training and test sets. RF and RSF models were trained using a total of 115 measures as candidate predictors. The outcome of interest was the earliest of incident dementia, physical disability, or death. Results: The primary endpoint occurred in 10.5% of participants. Discrimination was similar between the models: sensitivity (~0.75), specificity (~0.57), positive predictive value (~0.17), time dependent AUC (~0.71), and Harrell's concordance (~0.73). Calibration was likewise similar, Brier score (~0.09). Discussion: The RF and RSF models exhibited comparable discrimination and calibration. We conclude that RSF may not always lead to more accurate predictions of outcomes compared to RF. Further examination in different clinical trial cohorts is needed to better understand the context in which adding time into outcomes risk modeling adds value.

Indexed as

AspirinClinical TrialDisability-free LongevityPredictive ModelingRandom ForestRandom Survival Forest

Identifiers

PMID41757198
PMCPMC12934879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.